MiCo BioMed Co Ltd
KOSDAQ:214610
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
KR |
Intrinsic Value
The intrinsic value of MiCo BioMed Co Ltd (214610) under the Base Case is 1 825.96 KRW per share. Compared with the current market price of 2 290 KRW, the stock appears Overvalued by 20% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -91% last year to 3.9% by 2031. Revenue grows about -19% a year over the next five years, after falling about 25% a year over the last five years.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What MiCo BioMed Does
MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips.
- Headquarters
- Korea KR
- IPO date
- Jun 22, 2015
Earnings Waterfall
MiCo BioMed Co Ltd
The intrinsic value for MiCo BioMed Co Ltd (214610) under the Base Case is 1 825.96 KRW.
Compared with the current market price of 2 290 KRW, the stock appears Overvalued by 20% .